Cargando…
Improving therapeutic HPV peptide-based vaccine potency by enhancing CD4+ T help and dendritic cell activation
BACKGROUND: Effective vaccination against human papillomavirus (HPV) represents an opportunity to control cervical cancer. Peptide-based vaccines targeting HPV E6 and/or E7 antigens while safe, will most likely require additional strategies to enhance the vaccine potency. METHODS: We tested the HPV-...
Autores principales: | Wu, Chao-Yi, Monie, Archana, Pang, Xiaowu, Hung, Chien-Fu, Wu, T-C |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3000388/ https://www.ncbi.nlm.nih.gov/pubmed/21092195 http://dx.doi.org/10.1186/1423-0127-17-88 |
Ejemplares similares
-
Vascular disrupting agent DMXAA enhances the antitumor effects generated by therapeutic HPV DNA vaccines
por: Peng, Shiwen, et al.
Publicado: (2011) -
Combination of apigenin treatment with therapeutic HPV DNA vaccination generates enhanced therapeutic antitumor effects
por: Chuang, Chi-Mu, et al.
Publicado: (2009) -
Treatment with Imiquimod enhances antitumor immunity induced by therapeutic HPV DNA vaccination
por: Chuang, Chi-Mu, et al.
Publicado: (2010) -
Cervarix(™): a vaccine for the prevention of HPV 16, 18-associated cervical cancer
por: Monie, Archana, et al.
Publicado: (2008) -
Enhancing DNA vaccine potency by co-administration of xenogenic MHC-class-I DNA
por: Kang, Tae Heung, et al.
Publicado: (2009)